Comparative Effectiveness Research using an intent-to-treat approach in 8 clinics in South Carolina. The investigators will assess 4 efficacious approaches to controlling treatment-resistant hypertension (TRH): Aldosterone Antagonist, Referral to Hypertension Specialist, Renin Treatment-Guided Therapeutics, and combination of Hypertension Specialist and Renin Treatment-Guided Therapeutics. Patients with TRH are evaluated with the BpTRU device for an accurate and representative blood pressure measure on two occasions before entry into the study. Qualitative data from focus group discussions with practice staff, and patient surveys and interviews will provide contextual data to help explain why some interventions are more acceptable and successful than others.
This is Comparative Effectiveness Research conducted in the real world of under-resourced primary care clinics in South Carolina. Four arms of the study are identified with two clinics/arm enrolling and following patients with TRH. The goal is to compare rates of BP control according to American Heart Association guidelines among the 4 arms, along with clinic and patient satisfaction with each approach. Our hypothesis is that defining pathophysiological mechanisms (e.g. renin treatment-guided therapeutics) with or without referral to a hypertension specialist will improve blood pressure control over adding an aldosterone antagonist in eligible patients or just referring patients to a hypertension specialist. This mixed-methods design captures medical and qualitative data to not only describe the outcome of blood pressure control, but to assess the impact of the four interventions on staff and patient satisfaction. Key patient data includes demographics, visits, blood pressure values, medications and laboratory data. Focus group discussions with practice staff before and after the study will document early attitudes toward each arm, any practice changes needed to implement each arm and any burdens of the intervention on the practice. Patient surveys and interviews will assess their satisfaction with each intervention along with their experiences in participating in this research project. Treatment Resistant Hypertension is a common medical condition, and relatively ineffective treatment regimens are a significant contributing factor. The long-term goal is to establish practice and effective approaches for controlling blood pressure and reducing clinical complications and related health disparities.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
70
Patients are treated based upon their renin levels according to an approved algorithm.
Patients are referred to a hypertension specialist.
Spironolactone 12.5 - 25mg daily
AnMed
Anderson, South Carolina, United States
Beaufort Jasper Hampton Comprehensive Health
Beaufort, South Carolina, United States
McLeod Family Medicine Center
Florence, South Carolina, United States
Family Diagnostics
Holly Hill, South Carolina, United States
Lovelace Family Medicine
Prosperity, South Carolina, United States
Carolina Medical Affiliates
Spartanburg, South Carolina, United States
Spartanburg Regional Health Services
Spartanburg, South Carolina, United States
Palmetto Primary Care
Summerville, South Carolina, United States
blood pressure control
Blood pressure control will be assessed according to guidelines established by American Heart Association.
Time frame: four months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.